logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > API Active Pharmaceutical Ingredient > Cefixime CAS 79350-37-1 API Active Pharmaceutical Ingredient

Cefixime CAS 79350-37-1 API Active Pharmaceutical Ingredient

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 79350-37-1

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Bag,Drum

Delivery Time: 7-15 days

Payment Terms: L/C, D/A, T/T, Western Union

Supply Ability: TON

Get Best Price
Highlight:

CAS 79350-37-1 Cefixime

,

Cefixime CAS 79350-37-1

CAS NO::
79350-37-1
Appearance::
White To Off White Powder Or Off White Crystal Powder
Molecular Formula::
C16H15N5O7S2
Molecular Weight::
453.45000
EINECS NO::
616-684-4
MDL NO::
MFCD00865020
CAS NO::
79350-37-1
Appearance::
White To Off White Powder Or Off White Crystal Powder
Molecular Formula::
C16H15N5O7S2
Molecular Weight::
453.45000
EINECS NO::
616-684-4
MDL NO::
MFCD00865020
Cefixime CAS 79350-37-1 API Active Pharmaceutical Ingredient

Product Description:

Product Name: Cefixime CAS NO: 79350-37-1

 

 

Synonyms:

8-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-4-ethenyl-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid;

(carboxymethoxy)imino)acetylamino)-3-ethenyl-8-oxo-,(6r-(6-alpha,7-beta(z)));

 

 

Chemical & Physical Properties:

Appearance: White to off white powder or off white crystal powder

Assay :≥99.0%

Density: 1.85 g/cm3

Melting Point: 218-225℃

Water Solubility: 55.11 mg/L

Storage Condition: Hygroscopic, Refrigerator, Under Inert Atmosphere

 

 

Safety Information:

Safety Statements: S22-36/37-45

HS Code: 2941905990

WGK Germany: 3

Risk Statements: R42/43

Hazard Code: Xn

 

 

Orally active, third generation cephalosporin antibiotic. The third-generation oral cephalosporin class of broad-spectrum antibiotics, has strong antibacterial effect on Gram-positive bacteria such as Streptococcus, and Gram-negative bacteria such as Neisseria gonorrhoeae, Haemophilus influenzae, , as well as E. coli , Klebsiella pneumoniae, Proteus mirabilis, which are resistance to cefaclor, cephalexin, cefadroxil resistant, and is stable for β-lactamase produced by various bacteria. Long-acting, efficient and can be administered once a day. Clinically used for respiratory tract infections,urinary tract infections and biliary tract infections caused by susceptible strains.

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.